Short Description
Quantitatively measures human Lactate Dehydrogenase (LDH) levels in serum, plasma, and tissue samples.
ADME Research Domain
Metabolism
Description
CytoFinal™ Human Lactate Dehydrogenase (LDH) ELISA Kit offers a sensitive, specific in vitro assay to quantify LDH concentrations in serum, plasma, tissue homogenates, and other biological fluids, providing a reliable tool for metabolic and cytotoxicity studies.
Features
High sensitivity detection with a lower limit of <0.06 ng/mL, enabling precise quantification of low-abundance LDH molecules.
Excellent specificity with minimal cross-reactivity, ensuring accurate measurement of LDH without interference from analogues.
Sandwich ELISA format with pre-coated 96-well plates, TMB colorimetric readout, and HRP-conjugated detection reagents for robust quantitative analysis.
Broad test range of 0.156-10 ng/mL suitable for diverse sample types, including serum, plasma, cell lysates, and culture supernatants.
Process Relevance
Enables precise monitoring of LDH levels to assess metabolic status and cytotoxicity in experimental workflows.
Application Stage
Applicable in drug discovery, toxicology screening, and in-process clinical research.
Applications
Suitable for quantitative ELISA detection of LDH in serum, plasma, tissue homogenates, cell lysates, and cell culture supernatants for ADME profiling studies.
Target
Human Lactate Dehydrogenase (LDH) antigen
Detection Method
Colorimetric
Sample Type
Serum, plasma, tissue homogenates, cell lysates, cell culture supernatants and other biological fluids.
Assay Measures
Quantitative
Research Areas
Cellular metabolism, toxicology, oncology, clinical biomarker studies, pharmacokinetics (ADME), metabolic disorder research, etc.